Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07527975 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of RP-L102

StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Long-Term Follow-up: Phase I/II clinical study to evaluate the safety and efficacy of the infusion of RP-L102
Trial Details
NCT Number NCT07527975
Lead Sponsor Rocket Pharmaceuticals Inc.
Conditions
(from sponsor)		 Fanconi Anemia
Related terms Fanconi Anemia
Enrollment 14 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov